MORRISVILLE, N.C. — Carolina Molecular (“CMI”), a premier molecular testing laboratory and NGS foundry, today announced it has been named a certified sequencing service provider by Alamar Biosciences. Through this designation, CMI is now accepting ARGO™ HT libraries from the growing installed base of Alamar Biosciences’ customers. This marks a significant expansion of CMI’s multi-omic capabilities, providing researchers with a seamless, validated workflow that bridges ultra-sensitive protein detection with industry-leading sequencing accuracy.

“We are thrilled to support Alamar Biosciences as a sequencing partner for the ARGO™ HT system,” said John Corliss, Co-Founder of CMI. “Alamar NULISA™ libraries will be sequenced with the data quality and turn-around time needed for complex studies, from discovery-based research projects to longitudinal translational studies.”

Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar’s platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics.

As a certified sequencing service provider, CMI ensures that libraries generated by the Alamar ARGO™ HT system are sequenced with the optimized performance metrics required for multiplex proteomics. This service expansion further solidifies CMI’s role as a hub for researchers seeking to integrate high-dimensional protein profiling with advanced genomic readouts.